<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Tao R</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Phosphodiesterase type 5-inhibitors (PDE5is) are the first-line treatment for patients with diabetes mellitus-induced erectile dysfunction (DMED), however, some patients are non-responser to PDE5is. We performed a perspective, randomized, comparative study to explore the efficacy of low intensity extracorporeal shock wave treatment (Li-ESWT) combined with vacuum erectile device (VED) in the treatment of DMED patients who were unresponsive to PDE5is.&lt;h4>Methods&lt;/h4>One hundred and five eligible patients were randomly divided into three groups: group A (VED), group B (Li-ESWT) and group C (VED plus Li-ESWT). Follow-up was conducted at 4 weeks, 8 weeks and 12 weeks after the end of treatment. The erectile function was estimated by the international index of erectile funct</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>937958</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9259797</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial.</pubmed_title><pmcid>PMC9259797</pmcid><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Xiong L</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Zhou S</pubmed_authors><pubmed_authors>Jia C</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Xiang J</pubmed_authors><pubmed_authors>Ji J</pubmed_authors><pubmed_authors>Lv J</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Tang Q</pubmed_authors><pubmed_authors>Tao R</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Efficacy of Li-ESWT Combined With VED in Diabetic ED Patients Unresponsive to PDE5is: A Single-Center, Randomized Clinical Trial.</name><description>&lt;h4>Introduction&lt;/h4>Phosphodiesterase type 5-inhibitors (PDE5is) are the first-line treatment for patients with diabetes mellitus-induced erectile dysfunction (DMED), however, some patients are non-responser to PDE5is. We performed a perspective, randomized, comparative study to explore the efficacy of low intensity extracorporeal shock wave treatment (Li-ESWT) combined with vacuum erectile device (VED) in the treatment of DMED patients who were unresponsive to PDE5is.&lt;h4>Methods&lt;/h4>One hundred and five eligible patients were randomly divided into three groups: group A (VED), group B (Li-ESWT) and group C (VED plus Li-ESWT). Follow-up was conducted at 4 weeks, 8 weeks and 12 weeks after the end of treatment. The erectile function was estimated by the international index of erectile funct</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-21T17:28:55.809Z</modification><creation>2022-07-22T07:50:23.616Z</creation></dates><accession>S-EPMC9259797</accession><cross_references><pubmed>35813628</pubmed><doi>10.3389/fendo.2022.937958</doi></cross_references></HashMap>